Chronic NOS Inhibition Affects Oxidative State and Antioxidant Response Differently in the Kidneys of Young

M Majzunova1,2, M Kvandova3, A Berenyiova1

  • 1Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia.

Insights

Nitric oxide (NO) deficiency and oxidative stress contribute to hypertension. This study shows that while antioxidant systems balance NO deficiency in normotensive rats, impaired activity in hypertensive rats leads to kidney damage.

Area of Science:

  • Nephrology
  • Cardiovascular Research
  • Oxidative Stress Biology

Background:

  • Nitric oxide (NO) deficiency and oxidative stress are implicated in hypertension and hypertensive renal disease.
  • Radical molecules like NO and superoxide anions interact, causing oxidative damage to organs, particularly the kidneys.
  • Understanding the interplay between NO metabolism and antioxidant responses is crucial for managing hypertensive renal conditions.

Purpose of the Study:

  • To investigate the impact of chronic neuronal and non-specific nitric oxide synthase (NOS) inhibition on the oxidative state and antioxidant response in the kidneys of normotensive and spontaneously hypertensive rats.
  • To assess the resulting oxidative damage to renal tissues under conditions of NO deficiency.
  • To elucidate the role of the antioxidant defense system in mitigating or exacerbating kidney damage during NO deficiency in hypertension.

Main Methods:

  • Utilized young male normotensive Wistar rats (WRs) and spontaneously hypertensive rats (SHRs).
  • Administered 7-nitroindazole (7-NI) or N(G)-nitro-L-arginine-methyl ester (L-NAME) to inhibit NOS, alongside a control group, for six weeks.
  • Analyzed systolic blood pressure, total NOS activity, protein nitration (3-nitrotyrosine expression), and superoxide dismutase (SOD) isoform expression and activity.

Main Results:

  • L-NAME increased systolic blood pressure in normotensive rats; 7-NI had no effect on blood pressure.
  • Chronic NOS inhibition attenuated total NOS activity in hypertensive rats (SHR+7-NI, SHR+L-NAME).
  • Protein nitration increased in hypertensive rats (SHR+7-NI, SHR+L-NAME) but decreased in normotensive rats treated with 7-NI (WR+7-NI).
  • SOD2 and SOD3 expressions decreased in normotensive rats under NOS inhibition but increased in hypertensive rats.
  • Antioxidant defense systems attempted to balance oxidation in normotensive rats, but impaired activity in hypertensive rats led to protein oxidative damage in the kidneys.

Conclusions:

  • The antioxidant defense system is vital for maintaining oxidative balance during nitric oxide deficiency.
  • In normotensive rats, a functional antioxidant system counteracts NO deficiency-induced oxidative stress.
  • Impaired antioxidant activity in hypertensive rats exacerbates kidney damage, evidenced by increased protein nitration and oxidative damage.
  • These findings highlight the critical role of antioxidant capacity in the pathogenesis of hypertensive renal disease.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
658
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.2K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
846
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
505